Investor insights
Sectors invested in
Funding rounds participated in
$13M sweet spot round size
Most of their 9 investments are in rounds between $10M and $16M
Basic info
Industry
Sectors
Date founded
1986
Investments made
Glyphic Biotechnologies raised $40K on January 19, 2022
Investors: QIAGEN
ArcherDX, Inc. raised $35M on March 20, 2018
Investors: PBM Capital Group, Boulder Ventures, Longwood Fund and QIAGEN
Exosome Diagnostics raised $16M on January 7, 2016
Investors: Forbion, Blue Ridge Investment Co, ARCUS VENTURES LTD and QIAGEN
Protagen AG raised $12M on December 17, 2014
Investors: MIG Capital, NRW.BANK and QIAGEN
Exosome Diagnostics raised $27M on March 11, 2014
Investors: b-to-v Partners AG, Forbion, ARCUS VENTURES LTD, Tiger Infrastructure Partners and QIAGEN
Drug Response Dx GmbH raised undisclosed on January 8, 2013
Investors: High-Tech Gründerfonds and QIAGEN
Xagenic raised $10M on January 30, 2012
Investors: CTI CAPITAL and QIAGEN
Undisclosed raised $13M on August 3, 1999
Investors: Techno Venture Management, Alafi Capital Corp and QIAGEN
Ingenium Pharmaceuticals GmbH raised undisclosed on June 1, 1998
Investors: QIAGEN
Funding rounds raised
Total raised
$4M
from 2 investors over 2 rounds
QIAGEN raised $4M on October 22, 2021
Investors: U.S. Department of Health and Human Services (HHS) and united-states-department-of-defense